Time: September 21, 2012 from 1pm to 2pm
Location: TuDiabetes homepage
Website or Map: http://www.tudiabetes.org
Event Type: videochat
Organized By: Emily Coles
Latest Activity: Sep 21, 2012
Export to Outlook or iCal (.ics)
1-2pm PST
4-5pm EST
9-10pm GMT
The research in Dr. Bluestone's laboratory concerns the fundamental events that regulate T-cell activation and development during immune responses to autoantigens and transplantation antigens. The goal of this research is to gain insights which will help in the development of a new generation of toleragenic drugs that will "turn off" selected parts of the immune system, leaving the disease-fighting capabilities intact.
Dr. Bluestone's lab has also started the JDRF Center for Islet Transplantation, a comprehensive research and clinical program aimed at producing rapid clinical advances in islet transplantation. The center combines cutting-edge programs in both immunobiology and transplant biology with established clinical expertise in islet transplantation and monitoring technology. In addition, they have developed a COLLABORATIVE CENTER FOR CELL THERAPY. The goals of these centers are to develop and exploit novel tolerogenic drugs for the treatment of Type 1 Diabetes.
Manny Hernandez(Co-Founder, Editor, has LADA)
|
Bradford (has type 1) |
Lorraine (mother of type 1) |
Marie B (has type 1) |
|
|
|
|
|
|
This site complies with the HONcode standard for trustworthy health information: verify here.
© 2013 A community of people touched by diabetes, run by the Diabetes Hands Foundation.

RSVP for Live videochat with Jeffrey Bluestone, Ph.D., UCSF Executive Vice Chancellor and Provost; Professor of Medicine, Pathology, Microbiology & Immunology to add comments!
Join Diabetes community by Diabetes Hands Foundation: TuDiabetes